SAN FRANCISCO, CA--(Marketwired - June 03, 2014) - Today LifeNexus, creator of iChip®, and Pulse8, the leading provider of risk adjustment analytics, announced a combined offering to help health plans with Medicare Advantage and insurance exchange products to identify and address risk adjustment and quality more effectively at the point of the care, when it is most valuable.
Pulse8 identifies the health risk associated with a payer's population, including a member's care gaps and suspecting and persisting conditions; and iChip, as a consumer-controlled mobile platform, delivers such analytics and information at the point of care. Together LifeNexus and Pulse8 provide impactful member-specific information to doctors so they can more appropriately code risk and diagnose and treat each patient.
"With the expected reduction in Medicare reimbursements and the impact of risk adjustment to plans on the exchange, it is more important than ever for health plans to manage cost and quality as effectively as possible," said David R. Strand, CEO of LifeNexus. "We are pleased to add Pulse8 to the iChip platform to help plans further leverage the point of care to address these critical issues."
By integrating Pulse8's industry-leading risk adjustment analytics, iChip delivers them to the doctor at the point of care as part of the iChip Health Record. This relevant and meaningful record also includes health plan and member-entered data such as medical history, allergies, medications, confirmed eligibility, advanced directives, 90-day healthcare visits, and more. It is shared by the member at the point of care via an iChip-enabled health insurance card or iChip's smartphone app in a way that can be conveniently accessed and used by their doctor.
"We know everyone carries their health insurance card, and more and more Americans use smartphones. By delivering Pulse8 analytics on iChip enabled member cards and smartphones, providers will have more complete, accurate and actionable information during each patient visit," said John Criswell, CEO of Pulse8. "This innovative solution is the smartest and most cost-effective method for health plans to share meaningful information with patients and doctors to improve care and reduce costs."
Pulse8 is a cutting-edge healthcare technology and analytics provider that delivers an unprecedented view into risk adjustment enabling health plans to achieve the highest financial impact in the Commercial Health Exchanges, Medicare Advantage and Medicaid markets. Pulse8's innovative and unique risk adjustment methodologies ensure its clients outperform the marketplace. Utilizing transparent and flexible business intelligence tools, Pulse8 allows real-time visibility into member and provider behaviors so its clients can apply the most cost-effective and appropriate interventions. For additional company information, or to schedule a demonstration, contact Scott Filiault at 732-570-9095 or firstname.lastname@example.org. Please visit www.pulse8.com and follow Pulse8 on twitter @Pulse8News for timely risk adjustment, analytics and industry updates.
LifeNexus is a San Francisco-based healthcare technology company and the creator of iChip®, a patented technology. iChip is a mobile platform that uniquely delivers personalized health information and analytics to consumers and providers at the point and time of care to help improve healthcare experiences, health outcomes and financial results. For more information or to schedule a demonstration contact Jamie Hall at 415-279-4889 or email@example.com. To learn more, visit www.iChip.com.
iChip® is a registered trademark of LifeNexus.
Image Available: http://www.marketwire.com/library/MwGo/2014/6/2/11G016457/Images/iChip-Horizontal-w-by-LN-Under-1124450360132.jpg
Image Available: http://www.marketwire.com/library/MwGo/2014/6/2/11G016457/Images/Pulse8_Logo-1351349973312.jpg